PCI Pharma Services

At PCI Pharma Services, sustainable procurement practices are central to our ESG Program as we work?to create?a?net-zero supply chain?by 2045. Our sustainable procurement program is designed to achieve our goals by putting policies, actions, and measurements in place to prevent negative environmental and social impacts throughout every stage of our supply chain. By integrating ESG principles into our procurement of goods and services, we?can?reduce our global footprint and ultimately transform our business practices as your world leading CDMO ?https://lnkd.in/e7PZyU-w #ESG? #Sustainability #LetsTalkFuture

We are proud to be recognized as one of the Top 100 Healthcare Technology Companies by The Healthcare Technology Report for the second consecutive year! The Top 100 list includes the most important and influential healthcare technology companies worldwide, categorized across different sectors such as software, medical devices, biotechnology, consumer internet, and more. PCI Pharma Services was chosen for its investment and dedication to providing an innovative digital experience to clients and enhancing their supply chain visibility and management. Digital transformation is a important differentiator in our business strategy, which is clearly demonstrated through our pci | bridge? platform. This platform is designed to provide clients with real-time insights into their clinical and commercial portfolio of work at our sites around the world. ? ?https://lnkd.in/eWZSSqiw #LetsTalkFuture #ExperienceThePower? #pcibridge

Press Release: PCI Pharma Services collaborates with theranostics specialist company?ChiRhoClin, Inc.?to prevent the shortage of critical orphan pancreatic drug. ? ChiRhoClin is a theranostics company specializing in orphan drugs for the gastrointestinal and radiological?sectors.?Its intravenous product, ChiRhoStim?, is essential for diagnosing pancreatic cancer and exocrine dysfunction.? ? Working closely with the FDA CDER Drug Shortage Team, ChiRhoClin secured approval for the commercial release of the first process performance qualification (PPQ) batch, manufactured at PCI Pharma Services's Bedford, NH facility and packaged in Philadelphia. While the commercialization process usually requires three PPQ runs after CDMO tech transfer, interim approval was granted because of the drug's established commercial status at PCI. This streamlined, "under one corporate roof" process expedited drug product release and shortened the batch's time to market by approximately three months.? ? Full Press Release & Product Supply Details:? ? https://lnkd.in/efUqV9kv ? #CDMO #Lyophilization #SterileDrugManufacturing ? #LetsTalkFuture

What happens when your world leading CDMO commits to ESG? You get world changing results. ? Since formalizing our Global Environmental Social Governance (ESG) program in 2021, we have been learning, measuring, and improving our environmental and social impact by committing to ambitious targets across nine impact categories. We’re continuously investing in ESG initiatives and rethinking how we conduct business. For PCI Pharma Services, ESG is not just a program or an initiative. It is part of our DNA; is a way of thinking and acting and expresses our core values: people, communities, and accountability. https://lnkd.in/eGiQKTdk #ESG #Sustainability #LetsTalkFuture

In the latest edition of Contract Pharma, William Welch, Executive Director of Market Development, discusses key considerations for achieving successful commercialization of drug device combination products. From early-phase clinical trials to commercial launches, considerations such as drug product device compatibility, device strategy, manufacturability,?and packaging design must be carefully navigated. Successful commercialization of drug device combination products requires a multidisciplinary holistic approach, combining expertise in both drug products and medical devices. ? Learn more here:?https://lnkd.in/ebbwJTH9 #CDMO #AdvancedDrugDelivery #DrugDeviceCombination #LetsTalkFuture ?

Early phase drug product development and manufacturing are pivotal steps in transforming promising candidates into life changing therapies. In the fast-paced drug development landscape, collaboration between biopharmaceutical companies and Contract Development and Manufacturing Organizations (CDMOs) has become indispensable for managing the complexities of this process. Explore our latest article in SENGLOBAL LTD's International Biopharmaceutical Industry journal, Unlocking Early Drug Development Potential with CDMO Expertise, to learn how CDMO's play a crucial role in mitigating risks and accelerating early-phase drug development, from pharmaceutical development through to large-scale production. https://lnkd.in/eRn_3aNi #CDMO #DrugDevelopment #DrugManufacturing #LetsTalkFuture

Over the past decade, the EU's GMP regulations have seen significant changes, including updates to three chapters, six revised Annexes, new GMP guidance for ATMPs, and the impact of Brexit. Shawn Murtough, Director of Quality and Regulatory Services at PCI Pharma Services, shared insights with Contract Pharma for their special 25th-anniversary report on major EU regulatory changes that have impacted the industry in recent years. Read more here:?https://lnkd.in/e54pbKkv #ClinicalTrials #CDMO #GMPRegulations #LetsTalkFuture

You can still register for the free East Coast November ExpertXchange seminars! Join us at one of the co-hosted seminars with Avid Bioservices and Worldwide Clinical Trials, where we will explore strategies for drug development, manufacturing, and clinical trial excellence. Dates & Venues: - Raleigh, NC - November 12th | Embassy Suites by Hilton - Bridgewater, NJ - November 13th | The Bridgewater Marriott - Waltham, MA - November 14th | The Westin Waltham Boston Full seminar agenda, details & registration: https://lnkd.in/eVqp_xQS #ExpertExchange #DrugDevelopment #CDMO #LetsTalkFuture

News: PCI Pharma Services have been awarded a Gold rating in the Better Stands assessment by AbraxysGlobal Ltd?for commitment to ESG at CPHI by applying sustainable principles to the design and afterlife of their stand. Our commitment to Environmental, Social, and Governance (ESG) principles goes beyond our facilities; we apply these values to all the events we participate in and host. At CPHI, our stand was designed and constructed using recyclable and reusable materials, including the framing and carpet. We also utilized energy-efficient LED lighting for all displays and fixtures. We know the impact we can make, locally and globally, and take great pride in demonstrating responsible and sustainable practices throughout our business. #ESG #Sustainability #LetsTalkFuture

In the latest PMPS supplement, PCI Pharma Services showcases comprehensive drug development, manufacturing, and packaging solutions. These solutions enhance product speed to market and create more significant opportunities for commercial success, emphasizing how advanced technology and ongoing investments meet global drug development needs throughout the product lifecycle - from manufacturing capabilities to clinical trial supply and commercialization. Click here to learn more: https://lnkd.in/dpfNWA9y ? #CDMO #DrugDevelopment #PharmaManufacturing #LetsTalkFuture